Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
2025 · New England Journal of Medicine · 179 citations
https://doi.org/10.1056/nejmoa2504747
A
Ali Oğul
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
342
Citations
6
h-index
4
i10-index
Ali Oğul is an academic researcher from Memorial Ankara Hospital. The author has contributed to research in topics: Inflammatory Biomarkers in Disease Prognosis & Lung Cancer Treatments and Mutations & Lymphoma Diagnosis and Treatment. The author has an h-index of 6, co-authored 45 publications.
ORCID: 0000-0003-4886-7060Papers by this author
worksEffects of enhancer of zeste homolog 2 and mucin 1 expressions on treatment response in breast cancer
2023 · Revista da Associação Médica Brasileira · 2 citations
https://doi.org/10.1590/1806-9282.20221123
Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI
2025 · Biomarkers in Medicine · 1 citations
https://doi.org/10.1080/17520363.2025.2560797
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-87553-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat